Susanne Walz

Bioinformatician and Team Lead of the Software & Data Team @BiotypeDx

[BIOTYPE GmbH @BiotypeDx]

Treffen Sie BIOTYPE auf der Omnilab-Laborfachmesse „#LabCon2024“ am 24. April in Leipzig und erfahren Sie mehr über das MODAPLEX-System und wie einfach die Integration von Multigen-Tests in die Laborroutine sein kann.

📆 24 April 2024
📍 Stand Event 2, Vortrag: 11:30 Uhr

[BIOTYPE GmbH @BiotypeDx]

The first ever scientific publication of our MODAPLEX POLE/POLD1 Mutation Analysis Kit has been published! In early 2023 the publication was presented as a poster during that year’s ESMO congress and has now been accepted by a journal:

https://t.co/N41zZw1QWz

#MODAPLEX #Cancer

[BIOTYPE GmbH @BiotypeDx]

Today, we had the privilege of hosting the Prime Minister of the Free State of Saxony, Mr. Michael Kretschmer. Wilhelm Zörgiebel and Norman Gerstner shared an overview of the present advancements in molecular diagnostics and their role in precision medicine.

#BIOTYPE #MODAPLEX

[Science and Innovation at Cancer Research UK @CRUKresearch]

We're looking forward to seeing everyone in Paris for #MAP2023 today! Join us to hear from this field's global leaders as they discuss #PrecisionMedicine & #Oncology.

Registration is still open for a last-minute tickets: https://t.co/Nq7PQEr9Me

@myESMO @GroupeUnicancer

[ESMO - Eur. Oncology @myESMO]

#MAP2023 kicking off in Paris this morning, three excellent days ahead looking into the latest science and education around #PrecisionOncology https://t.co/wFwMajVE2F

@GroupeUnicancer @CRUKresearch @FAndreMD @HaanenJohn @CharlesSwanton

[BIOTYPE GmbH @BiotypeDx]

🧬 MORE in ONE! High-end molecular diagnostics: We launched an upgrade of the MODAPLEX platform for multi-gene testing and molecular profiling.

The full press release on MODAPLEX and BIOTYPE can be found here: https://t.co/gw8Sx5WrPU

#MODAPLEX #BIOTYPE #molecularprofiling

[BIOTYPE GmbH @BiotypeDx]

Join BIOTYPE at the 35th European Congress of Pathology and discover our newly available #MODAPLEX platform and MODAPLEX assay portfolio (POLE/POLD1, MSI) for molecular analysis of actionable biomarkers!

📆 9 – 13 September 2023
🚩Ireland
📍 Booth # 33

#ESPCongress #Pathology

[BIOTYPE GmbH @BiotypeDx]

🔬 BIOTYPE GmbH and STRATIFYER Molecular Pathology GmbH are partnering to develop innovative diagnostic tests to improve outcomes for patients with bladder cancer: https://t.co/g9WreleYKZ

#BIOTYPE #MODAPLEX #diagnostics #bladdercancer

[BIOTYPE GmbH @BiotypeDx]

At this year's #EHA2023 congress, we presented a poster that was created in collaboration with the Universitätsklinikum Carl Gustav Carus:
https://t.co/4btp56XNx5

Contact us to learn more about our innovative MODAPLEX platform: [email protected]

#hematology #leukemia

[BIOTYPE GmbH @BiotypeDx]

BIOTYPE is attending the #EHA2023 congress taking place from June 8th to 11th in Frankfurt, Germany.

If you're attending the congress, be sure to stop by our booth A116 to learn more about our fast & reliable soulution for acute myeloid leukaemia (AML) diagnostics.

#leukemia

[BIOTYPE GmbH @BiotypeDx]

📢 Meet BIOTYPE at the BIO International Convention!

We will showcase our innovative, high-quality solutions for precision diagnostics and #CDMO services.

5th – 8th June
Boston Convention and Exhibition Center / USA
Joint German Pavilion / Booth 1335-03

#BIO2023

[BIOTYPE GmbH @BiotypeDx]

We are excited to announce our distribution partnership with Gencurix, Inc. for Germany. Gencurix’ portfolio of various droplet digital PCR assays for detecting actionable mutations, makes them a perfect addition to our precision diagnostics solutions.

#BIOTYPE #Gencurix #ddPCR

[BIOTYPE GmbH @BiotypeDx]

Our Tech Leads Dr. Christoph Schanzenbach and Dr. Matthias Preussler presented a poster "Syndromic testing for medium throughput in one workflow: flexible molecular analysis with the MODAPLEX platform" during the 10th Gene Quantification event #GQ2023:

https://t.co/IORANKmSa3

[BIOTYPE GmbH @BiotypeDx]

The first ever scientific publication of our MODAPLEX POLE/POLD1 Mutation Analysis Kit was presented during this year’s ESMO Gynaecological Cancers Congress in Barcelona!

Publication: https://t.co/LVpNyFaZH6

#MODAPLEX #ESMOcongress #cancer

[qualitype @Qualitype_GmbH]

#stellenangebote
🚀 Softwareentwickler Java (m/w/d)
🚀 Eclipse RCP Entwickler (m/w/d)
🚀 Product Owner (m/w/d)
🚀 Junior Softwareentwickler (m/w/d)

[BIOTYPE GmbH @BiotypeDx]

👋 Join us at #MedLabME2023!

If you are attending @MedlabSeries visit BIOTYPE booth at the German pavilion and discover our broad portfolio for precision diagnostics.

📅 6th – 9th February
🚩 DWTC, Dubai
📍 Hall 6 / Booth Z6.C32

#MedlabMiddleEast #moleculardiagnostics #IVD

[Susanne Walz @SuseWalz]

@_WolfLab @NevenkaDudvars1 Congratulations Elmar!

[BIOTYPE GmbH @BiotypeDx]

BIOTYPE joins @Scientist.com

This B2B e-commerce platform is aiming to connect researchers with suppliers in the medical field for faster and economical medical research.

We look forward to supporting the community with our contract development services.

#FasterScience

[BIOTYPE GmbH @BiotypeDx]

If you are attending #MEDICA2022, join BIOTYPE team at booth G60 and discover our broad portfolio for molecular precision diagnostics:

👉 MOLECULAR DIAGNOSTIC TESTS
👉 CUSTOM SOLUTIONS
👉 MODAPLEX PLATFORM

📅 14th – 17th November
📍 Hall 3 / Booth G60

#diagnostics #healthcare

[qualitype @Qualitype_GmbH]

Als Product Owner (m/w/d) bei uns ähnelt dein Alltag einer CSI-Folge: Tätersuche, Verbrechensaufklärung und Erstellen von DNA-Täterprofilen. Ok, nicht wir machen das, aber unsere Kunden wie Polizei, Rechtsmedizinische Institute und DNA-Labore.

Mehr Infos: https://t.co/fQvpcA5kBJ